RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...
Here is a list of many popular retailers that are confirmed to be open on Veterans Day 2024, along with their store hours, ...
Rite-Aid filed for bankruptcy in July and closed nearly 74 stores this year. Walgreens CEO Tim Wentworth also announced ...
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...
Mizuho lowered the firm’s price target on CVS Health (CVS) to $66 from $73 and keeps an Outperform rating on the shares. The firm cut estimates following last week’s preannouncement.
Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...